Mitochondria: Role in ischemia, reperfusion and cell death;Mitocôndrias: Que papel na isquémia, reperfusão e morte celular?

Revista Portuguesa de Cardiologia

Volumn 22, Issue 2, 2003, Pages 233-254

  Monteiro, Pedro ^b   Oliveira, Paulo J ^b   Gonçalves, Lino ^a   Providência, Luís A ^b  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b NONE

Author keywords

Cardioprotection; Ischemia reperfusion; Mitochondria

Indexed keywords

CALCIUM; REACTIVE OXYGEN METABOLITE;

ADAPTATION; APOPTOSIS; CALCIUM HOMEOSTASIS; CELL DEATH; CELL ULTRASTRUCTURE; ELECTRON TRANSPORT; ENZYME ACTIVITY; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW;

CELL DEATH; HUMANS; MITOCHONDRIA, HEART; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; OXYGEN CONSUMPTION;

EID: 0037732545     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Ganz P, Braunwald E. Coronary blood flow and myocardial ischemia. In: Braunwald E, ed. Heart Disease - A Textbook of Cardiovascular Medicine. Philadelphia: W B Saunders 2000;1265-90.
2. Grynerg A, Demaison L. Fatty acid oxidation in the heart. J Cardiovasc Pharmacol 1996;28 (Suppl 1):S11-S17.
3. Grynberg A. Role of membrane lipids in myocardial cytoprotection. Arch Mal Coeur Vaiss 2000;93:175-82.
4. Kantor PF, Lucien A, Kozak R, et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 2000;86:487-9.
5. Spedding M, Tillement JP, Morin D, et al. Medicines interacting with mitochondria: anti-ischemic effects of trimetazidine. Therapie 1999;54:627-35.
6. Rahimtoola SH. A perspective on three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;72 (Suppl.V):123-35.
7. Berry GJ, Masek M. The pathology of hibernating myocardium. Nucl Med Commun 2002;23:303-9.
8. Hearse JD. Myocardial ischemia: can we agree on a definition for the 21st century? Cardiovasc Res 1994;28:1737-44.
9. Gerber BL, Wijns W, Vanoverschelde JL et al. Myocardial perfusion and oxygen consumption in reperfused noninfarcted dysfunctional myocardium after unstable angina: direct evidence for myocardial stunning in humans. J Am Coll Cardiol 1999;34:1939-46.
10. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 1999;79:609-34.
11. Sheean FH, Doerr R, Schmidt WG, et al. Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an important determinant of survival. J Am Coll Cardiol 1988;12:289-300.
12. Dispersyn GD, Borgers M, Flameng W. Apoptosis in chronic hibernating myocardium: sleeping to death? Cardiovasc Res 2000;45:696-703.
13. Bolli R, Triana JF, Jeroudi MO. Prolonged impairment of coronary vasodilation after reversible ischemia: Evidence for microvascular "stunning". Circ Res 1990;67:332-43.
14. Krause SM, Jacobus WE, Becker LC. Alterations in cardiac sarcoplasmic reticulum calcium transport in the postischemic "stunned" myocardium. Circ Res 1989;65:526-30.
15. Lazdunski M, Frelin C, Frelin P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 1985;17:1029-42.
16. 2+ exchange. Circ Res 1989;65:1045-56.
17. Przyklenk K, Kloner RA. Superoxide dismutase plus catalase improve contractile function in the canine model of the "stunned" myocardium. Cir Res 1986;58:148-56.
18. Bolli R, Patel BS, Jeroudi MO, et al. Iron-mediated radical reactions upon reperfusion contribute to myocardial "stunning". Am J Physiol 1990;259:H1901-H1911.
19. Koerner JE, Anderson BA, Dage RC. Protection against post-ischemic myocardial dysfunction in anesthetized rabbits with scavengers of oxygen-derived free radicals: superoxide dismutase plus catalase, N-2-mercaptoproprionyl glycine and captopril. J Cardiovasc Pharmacol 1991;17:185-91.
20. Dage RC, Anderson BA, Mao STJ, et al. Probucol reduces myocardial dysfunction during reperfusion after short-term ischemia in rabbit heart. J Cardiovasc Pharmacol 1991;17:158-65.
21. Ellis SG, Wynne J, Braunwald E, et al. Response of reperfusion-salvaged stunned myocardium to inotropic stimulation. Am Heart J 1984;107:13-9.
22. Arnold JM, Braunwald E, Sandor T et al. Inotropic stimulation of reperfused myocardium with dopamine: Effects on infarct size and myocardial function. J Am Coll Cardiol 1985;6:1026-34.
23. Heusch G, Schafer S, Kroger K. Recruitment of inotropic reserve in "stunned" myocardium by the cardiotonic agent AR-L 57. Basic Res Cardiol 1988;83:602-10.
24. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of Cytochrome c from mitochondria blocked. Science 1997;275:1129-31.
25. Kluck RM, Bossy-Wetzel E, Green DR, et al. The release of Cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-6.
26. Darley-Usmar V, Ragan I, Smith P, et al. The proteins of the mitochondrial inner membrane and their role in oxidative phosphorylation. In: Darley-Usmar V, Schapira AHV, eds. Mitochondria: ADN, Proteins and Disease. London, Portland Press 1994;1-25.
27. Zhang Y, Marcillat O, Giulivi C, et al. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem 1990;265: 16330-6.
28. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 1994;91:10771-8.
29. Beal MF. Aging, energy and oxidative stress in neurodegenerative diseases. Ann Neurol 1995;38:357-66.
30. Beal MF. Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Ann Neurol 1998;44:S110-S114.
31. Ferrari R. The role of mitochondria in ischemic heart disease. J Cardiovasc Pharmacol 1996;28 (Suppl 1):S1-S10.
32. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999;341:233-49.
33. Jennings RB, Reimer KA, Hill ML et al. Total ischemia in dog hearts in vitro. I. Comparison of high energy phosphate production, utilization and depletion, and of adenine nucleotide catabolism in total ischemia in vitro vs. severe ischemia in vivo. Circ Res 1981;49:892-900.
34. Doumen C, Wan B, Ondrejickova O. Effect of BDM, verapamil and cardiac work on mitochondrial membrane potential in perfused rat hearts. Am J Physiol 1995;269:H515-H523.
35. Jones DR, Abbott AE, Hill RC, et al, Gustafson RA, Murray GF. Preservation of adenosine 5′-triphosphate and mitochondrial function during hypercalcemic reperfusion using verapamil cardioplegia. Chest 1995;107:307-10.
36. 2+ transport by mitochondria and its possible role in cardiac contraction-relaxation cycle. Circ Res 1974;35 (Suppl 3):83-90.
37. ++ accumulation in rat cardiac myocytes. Am J Physiol 1983;244:H32-H38.
38. Nayler WG. The role of calcium in the ischemic myocardium. Am J Pathol 1981;102:262-70.
39. Jassem W, Fuggle SV, Rela M, et al. The role of mitochondria in ischemia/reperfusion injury. Transplantation 2002;73:493-9.
40. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979;59:527.
41. Morin D, Hauet T, Spedding M, et al. Mitochondria as target for antiischemic drugs. Adv Drug Deliv Rev 2001;49:151-74.
42. Ratych RE, Chuknyiska RS, Bulkley GB. The primary localization of free radical generation after anoxia/reoxygenation in isolated endothelial cells. Surgery 1987;102:122-31.
43. Kirshhenbaum LA, Singal PK. Antioxidant changes in heart hypertrophy: significance during hypoxia-reoxygenation injury. Can J Physiol Pharmacol 1992;70:1330-35.
44. Murphy BJ, Robin ED, Tapper DP, et al. Hypoxic coordinate regulation of mitochondrial enzymes in mammalian cells. Science 1984;223:707-9.
45. Gonzalez-Flecha B, Cutrin JC, Boveris A. Time course and mechanism of oxidative stress and tissue damage in rat liver subject to in vivo ischemia-reperfusion. J Clin Invest 1993;91:456-64.
46. Caraceni P, Ryu HS, Van Thiel DH, Borle AB. Source of oxygen free radicals produced by rat hepatocytes during postanoxic reoxygenation. Biochim Biophys Acta 1995; 1268; 249-54.
47. Schild L, Reinheckel T, Winswedel I, et al. Short-term energy production in isolated rat mitochondria by hypoxia/reoxygenation: involvement of oxidative protein modification. Biochem J 1997;328:205-10.
48. Shlafer M, Meyers CL, Adkins S. Mitochondrial hydrogen peroxide generation and activities of glutathione peroxidase and superoxide dismutase following global ischemia. J Moll Cell Cardiol 1987;19:1195-206.
49. Das DK, George A, Liu XK, et al. Detection of hydroxyl radical in mitochondria of ischemic-reperfused myocardium by trapping with salicylate. Biochem Biophys Res Commun 1989;16:1004-9.
50. Garcia-Ruiz C, Colell A, Mari M, et al. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. J Biol Chem 1997;272:11369-77.
51. Reinheckel T, Korn S, Mohring S, et al. Adaptation of protein carbonyl detection to the requirements of proteome analysis demonstrated for hypoxia/reoxygenation in isolated rat liver mitochondria. Arch Biochem Biophys 2000;376:59-65.
52. Ford DA. Alterations in myocardial lipid metabolism during myocardial ischemia and reperfusion. Prog Lipid Res 2002;41:6-26.
53. Chen JJ, Yu BP. Alterations in mitochondrial membrane fluidity by lipid peroxidation products. Free Rad Biol Med 1994;17:411-8.
54. Chen X, Gross RW. Phospholipid subclass-specific alterations in the kinetics of ion transport across biologic membranes. Biochemistry 1994;33:13769-74.
55. Pak JH, Bork VP, Norberg et al. Disparate molecular dynamics of plasmenylcholine and phosphatidylcholine bilayers. Biochemistry 1987; 26:4824-30.
56. +)-ATPase of cardiac sarcolemma. A possible role in myocardial ischemia. Biochim Biophys Acta 1984; 774:127-37.
57. Chen X, Gross RW. Potassium flux through gramicidin ion channels is augmented in vesicles comprised of plasmenylcholine: correlations between gramicidin conformation and function in chemically distinct host bilayer matrices. Biochemistry 1995;34:7356-64.
58. Costantini P, Chernyak BV, Petronilli V, et al. Modulation of mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J Biol Chem 1996;271:6746-51.
59. Nieminen AL, Byrne AM, Herman B, et al. Mitochondrial permeability transition in hepatocytes induced by t-BuOOH: NAD(P)H and reactive oxygen species. Am J Physiol 1997;272:C1286-C1294.
60. 2+] and membrane potential in ventricular myocytes exposed to anoxia-reoxygenation. Am J Physiol Heart Circ Physiol 1998;275:H484-H494.
61. Qian T, Niemimen AL, Herman B, et al. Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. Am J Physiol 1997;273: C1783-C1792.
62. Griffiths EJ, Ocampo CJ, Savage JS et al. Mitochondrial calcium transport pathways during hypoxia and reoxygenation in single rat cardiomyocytes. Cardiovasc Res 1998;39: 423-33.
63. Bolli R. Postischemic myocardial stunning. In Yellon DM and Jennings RB (eds.): Myocardial Protection: The Pathophysiology of Reperfusion and Reperfusion Injury. New York, Raven Press 1992.
64. Hearse DJ. Stunning: A radical re-view. Cardiovasc Drugs Ther 1991;5:853-76.
65. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulation in apoptosis and necrosis. Annu Rev Physiol 1998;60:619-42.
66. Zamzami N, Marchetti P, Castedo M, et al. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett 1996;384:53-7.
67. Hirsch T, Susin SA, Marzo I, Marchetti P, Zamzami N, Kroemer G. Mitochondrial permeability transition in apoptosis and necrosis. Cell Biol Toxicol 1998;14:141-5.
68. Skulachev VP. Mitochondria in the programmed death phenomena: A principle of biology: "It is better to die than to be wrong". IUBMB Life 2000;49:365-73.
69. Skulachev VP. How proapoptotic proteins can escape from mitochondria? Free Rad Biol Med 2000;29:1056-9.
70. Bernardi P. The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim Biophys Acta 1996;1275:5-9.
71. Ichas F, Mazat JP. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high -conductance state. Biochim Biophys Acta 1998;1366:33-50.
72. von Ahsen O, et al. Preservation of mitochondrial membrane structure and function after Bid or Bzx-mediated cytochrome c release. J Cell Biol 2000;123:44-8.
73. Zoratti M, Szabò I. The mitochondrial permeability transition. Biochim Biophys Acta 1995;1241:139-76.
74. Vercesi AE, Kowaltowski AJ, Grijalba MT, Meinicke AR, Castilho RF. The role of reactive oxygen species in mitochondrial permeability transition. Biosci Rep 1997;17: 43-52.
75. Bernardi P. Mitochondrial transport of cations: channels, exchangers and permeability transition. Physiol Rev 1999; 79:1127-55.
76. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000;6:513-9.
77. Marzo I, Brenner C, Zamzami N, et al. The permeability pore complex: a target for apoptosis regulation by caspases and Bcl-2 related proteins. J Exp Med 1998; 187:1261-71.
78. 2+ ions. J Biol Chem 1996;271:2929-34.
79. Baker JE, Felix CC, Olinger GN, Kalyanaraman B. Myocardial ischemia and reperfusion: direct evidence for free radical generation by electron spin resonance spectroscopy. Proc Natl Acad Sci USA 1988;85:2786-9.
80. Kristián T, Siesjo BK. Calcium-related damage in ischemia. Life Sci. 1996;59:357-67.
81. Zamzami N, Marchetti P, Castedo M, et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995;182:367-77.
82. Arora AS, Jones BJ, Patel TC, Bronk SF, Gores GJ. Ceramide induces hepatocytes cell death through disruption of mitochondrial function in the rat. Hepatology 1997;25:958-63.
83. Doliba NM, Doliba NM, Chang Q et al. Mitochondrial oxidative phosphorylation in heart from stressed cardiomyopathic hamsters. J Mol Cell Cardiol 1999;31:543-53.
84. Altschuld RA. Intracellular calcium regulatory system during ischemia and reperfusion. EXS 1996;76:87-97.
85. Frev TG and Mannella CA. The internal structure of mitochondria. TIBS 2000;15:319-24.
86. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extract; requirement for dATP and cytochrome c. Cell 1996;86:147-57.
87. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999;397:441-6.
88. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiate an apoptotic protease cascade. Cell 1997;91:479-89.
89. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12.
90. Kroemer G, Petit P, Zamzami N, et al. The biochemistry of programmed cell death. FASEB J 1995;9:1277-87.
91. Hockenbery DM, Oltavi ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-51.
92. Reed JC, Jurgensmeier JM, Matsuyama S. Bcl-2 family proteins and mitochondria. Biochim Biophys Acta 1998; 1366:127-37.
93. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal injury in ischemic myocardium. Circulation 1986;74:1124-36.
94. Ghosh S, Standen NB, Galiñanes M. Failure to precondition pathological human myocardium. J Am Coll Cardiol 2001;37:711-8.
95. Yin DP, Sankary HN, Chong AS, et al. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998;66:152-7.
96. Chance B, Williams GR. The respiratory chain and oxidative phosphorylation. Adv Enzymol Relat Subj 1956;17: 65-134.
97. Vanden Hoek TL, Becker LB, Shao Z, et al. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 1998;273:18092-8.
98. Grover GJ, Garlid KD. ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 2000;32:677-95.
99. Garlid KD. Opening mitochondrial KATP channel in the heart - what happens, and what does not happen. Basic Res Cardiol 2000;95:275-9.
100. Pain T, Yang XM, Critz SD, et al. Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals. Cir Res 2000;87:460-6.
101. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 1998;97:2463-9.
102. +channels: a possible mechanism of cardioprotection. Circ Res 1997;81:1072-82.
103. Ghosh S, Standen NB, Galiñanes M. Evidence for mitochondrial KATP channels as effectors of human myocardial preconditioning. Cardiovasc Res 2000;45:934-40.
104. Ohnuma Y, Miura T, Miki T, et al. Opening of mitochondrial KATP channel occurs downstream of PKC-ε activation in the mechanism of preconditioning. Am J Physiol Heart Heart Circ Physiol 2002;283:H440-H447.
105. Koretsune Y, Marban E. Mechanism of ischemic contracture in ferret hearts: relative roles of [Ca2+]i elevation and ATP depletion. Am J Physiol 1990;258:H9-C16.
106. Wang L, Cherednichenko G, Hernandez L, et al. Preconditioning limits mitochondrial Ca(2+) during ischemia in rat hearts: role of K(ATP) channels. Am J Physiol 2001;280: H2321-H2328.
107. Korge P, Honda HM, Weiss JN. Protection of cardiac mitochondria by diazoxide and protein kinase C: implications for ischemic preconditioning. Proc Natl Acad Sci USA 2002;99:3312-7.
108. Kannell WB. Role of diabetes in cardiac disease: conclusion from population studies. In: Zonaraich S, ed. Diabetes and the heart. Springfield, Illinois: Thomas Publishers, 1978:97-112.
109. Stone PH, Muller JE, Hartwell T. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to adverse prognosis. The MILIS study group. J Am Coll Cardiol 1989;14:49-57.
110. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993;72:1293-9.
111. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993;88:1264-72.
112. Pagliaro P, Gattullo D, Rastaldo R, Losano G. Ischemic preconditioning: from the first to the second window of protection. Life Sci 2001;69:1-15.
113. Baxter GF, Ferdinandy P. Delayed preconditioning of myocardium: current perspectives. Basic Res Cardiol 2001; 96:329-44.
114. Takano H, Tang XL, Bolli R. Differential role of K(ATP) channels in late preconditioning against myocardial stunning and infarction in rabbits. Am J Physiol 2000;279: H2350-H2359.
115. + channels mediate the delayed cardioprotective effect of adenosine A1 receptor activation. J Mol Cell Cardiol 1999;31:981-9.
116. Fryer RM, Hsu AK, Eells JT, Nagase H, Gross GJ. Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels. Circ Res 1999;84: 846-51.
117. Pell TJ, Yellon DM, Goodwin RW, Baxter GF. Myocardial ischemic tolerance following heat stress is abolished by ATP-sensitive potassium channel blockade. Cardiovasc Drugs Ther 1997;11:679-86.
118. Mei DA, Elliott GT, Gross GJ. KATP channels mediate late preconditioning against infarction produced by monophosphoryl lipid A. Am J Physiol 1996;271:H2723-H2729.
119. Qiu Y, Rizvi A, Tang XL, et al. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol 1997;273:H2931-H2936.
120. Schreck R, Rieber P, Bauerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the -nF-kappa B transcription factor and HIV-1. EMBO J 1991;10:2247-58.
121. Wink DA, Mitchell JB. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Rad Biol Med 1998;25: 434-56.
122. Takashi E, Wang Y, Ashraf M. Activation of mitochondrial K(ATP) channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway. Circ Res 1999;85:1146-53.
123. Ghosh S, Standen NB, Galinanes M. Preconditioning the human myocardium by simulated ischemia: studies on the early and delayed protection. Cardiovasc Res 2000;45: 339-50.
124. Bilinska M, Rudnicki S, Beresewicz A. Delayed attenuation of myocardial ischemia with repeated exercise in subjects with stable angina: a possible model for the second window of protection? Basic Res Cardiol 2000;95:418-23.
125. Dana A, Carroll R, Walker JM, Yellon DM. Exerciseinduced ischaemia causes both early and delayed myocardial adaptation during repeated exercise: a role for adenosine? Eur Heart J 2000;21(suppl):366 (abstract).
126. Yellon DM, Dana A. The preconditioning phenomenon: a tool for the scientist or a clinical reality? Circ Res 2000; 87:543-50.
127. Hill M, Takano H, Tang XL, Kodani E, Shirk G, Bolli R. Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance. Circulation 2001;104:694-9.
128. Leesar MA, Stoddard MF, Dawn B, Jasti VG, Masden R, Bolli R. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation. 2001;103:2935-41.